Skip to main content

Table 4 Sensitivity analysis for diagnostic performance (95% confidence intervals) compared to Medicare referent standards

From: Assembling and validating a heart failure-free cohort from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study

A. With addition of self-reported symptoms (orthopnea and/or paroxysmal nocturnal dyspnea)

  

HF according to Medicare

N (%)

Excluded from HF-free cohort

N

Included in HF-free cohort

N

NPV %

PPV %

Sens %

Spec %

Hospitalization for HF

+

293 (2.9%)

256

37

99.5% (99.3–99.7%)

9.5% (8.4–10.6%)

87.4% (83.6–91.2%)

75.1% (74.2–75.9%)

9766 (97.1%)

2436

7330

Principal diagnosis of HF

+

968 (9.6%)

746

222

97.0% (96.6–97.4%)

27.7% (26.0–29.4%)

77.1% (74.4–79.7%)

78.6% (77.8–79.4%)

9091 (90.4%)

1946

7145

Any diagnosis of HF

+

1135 (11.3%)

838

297

96.0% (95.5–96.4%)

31.1% (29.4–32.9%)

73.8% (71.3–76.4%)

79.2% (78.4–80.1%)

8924 (88.7%)

1854

7070

B. With addition of adjudicated heart failure

  

HF according to Medicare

N (%)

Excluded from HF-free cohort

N

Included in HF-free cohort

N

NPV %

PPV %

Sens %

Spec %

Hospitalization for HF

+

293 (2.9%)

236

57

99.3% (99.2–99.5%)

14.6% (12.9–16.4%)

80.5% (76.0–85.1%)

85.9% (85.2–86.6%)

9766 (97.1%)

1375

8391

Principal diagnosis of HF

+

968 (9.6%)

657

311

96.3% (95.9–96.7%)

40.8% (38.4–43.2%)

67.9% (64.9–70.8%)

89.5% (88.9–90.1%)

9091 (90.4%)

954

8137

Any diagnosis of HF

+

1135 (11.3%)

724

411

95.1% (94.7–95.6%)

44.9% (42.5–47.4%)

63.8% (61.0–66.6%)

90.1% (89.4–90.7%)

8924 (88.7%)

887

8037